drugset / Trial / NCT01201317

A Study to Investigate the Analgesic Efficacy of AZD2423 Compared With Placebo After 28 Days Treatment in Patients With Painful Diabetic Polyneuropathy

NCT01201317 ↗

Phase 2 Completed 134 enrolled AstraZeneca
RandomizedParallel-groupQuadruple-blindTreatment

Summary

A study to investigate the analgesic efficacy of AZD2423 compared with placebo after 28 days treatment in patients with painful diabetic polyneuropathy.

Timeline

Start
2010-09
Primary completion
2011-06
Completion
2011-06

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD2423 Unknown 20 mg —
Subject AZD2423 Unknown 150 mg —

Indications